Aggregated China Media News & Blogs



Merck Will Help Expand Access to HIV/AIDS Treatment In Least Developed Countries

Aggregated Source: ChinaCSR.com
February 14, 2007|

Merck has announced a reduction in the price of its HIV/AIDS medicine, STOCRIN (efavirenz), in the least developed countries of the world and those hardest hit by the epidemic.

Original URL: Click here to visit original article
Copyright ChinaCSR.com
Print This Post Print This Post | Email To Friend

1 Stars2 Stars3 Stars4 Stars5 Stars6 Stars7 Stars8 Stars9 Stars10 Stars

46 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 1046 Votes | Average: 3.72 out of 10 (46 votes, average: 3.72 out of 10)


Related Info:
  • Merck Recalls Problematic Vaccine In China
  • Proportion Of Beijing's Service Industry Reaches Level Of Developed Countries
  • Pionetics Begins Distribution of Consumer Water Treatment System
  • Jiangxi Building Wastewater Treatment Plants
  • China: Release for Medical Treatment Rejected

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |